Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

334.50p
   
  • Change Today:
      8.00p
  • 52 Week High: 445.00
  • 52 Week Low: 232.50
  • Currency: UK Pounds
  • Shares Issued: 106.09m
  • Volume: 185,583
  • Market Cap: £354.88m
  • RiskGrade: 125
  • Beta: 0.00

Latest ShareCast News

Oxford Biomedica reports first-half revenue growth

By Josh White

Date: Monday 23 Sep 2024

(Sharecast News) - Oxford Biomedica, a prominent gene and cell therapy company, reported significant revenue growth alongside strategic advancements in its interim results on Monday.

OXB Regulatory News

Total Voting Rights 02-Jun-2025 07:00 RNS
Grant of options 16-May-2025 17:52 RNS
Total Voting Rights 01-May-2025 07:00 RNS
Person Closely Associated Dealing 30-Apr-2025 16:49 RNS
Holding(s) in Company 29-Apr-2025 18:14 RNS

OXB News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 334.50p
Change Today 8.00p
% Change 2.45 %
52 Week High 445.00
52 Week Low 232.50
Volume 185,583
Shares Issued 106.09m
Market Cap £354.88m
Beta 0.00
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
30.87% below the market average30.87% below the market average30.87% below the market average30.87% below the market average30.87% below the market average
17.39% above the sector average17.39% above the sector average17.39% above the sector average17.39% above the sector average17.39% above the sector average
Price Trend
33.08% below the market average33.08% below the market average33.08% below the market average33.08% below the market average33.08% below the market average
4.35% above the sector average4.35% above the sector average4.35% above the sector average4.35% above the sector average4.35% above the sector average
Income Not Available
Growth
2.91% above the market average2.91% above the market average2.91% above the market average2.91% above the market average2.91% above the market average
10.34% below the sector average10.34% below the sector average10.34% below the sector average10.34% below the sector average10.34% below the sector average

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 04-Jun-2025

Time Volume / Share Price
16:35 12,204 @ 334.50p
16:35 4 @ 334.50p
16:35 10 @ 334.50p
16:35 41 @ 334.50p
16:35 27 @ 334.50p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page